Drug:
Reaction: PARAESTHESIA
20250101 - 20251231
No. 2501 - 2600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 2501 | 25337983 |
BR |
73 | 1 |
Skin exfoliation, Salivary hyposecretion, Oral discomfort, Decreased appetite, Gait disturbance, Dry skin, Asthenia, Malaise, Inappropriate schedule of product administration, Mastication disorder, Dysgeusia, Paraesthesia, Skin atrophy, Off label use, Palmar-plantar erythrodysaesthesia syndrome, Weight decreased, |
||||
TALQUETAMAB, TALQUETAMAB, |
||||
| 2502 | 25338014 |
US |
61 | 2 |
Unresponsive to stimuli, Confusional state, Feeling abnormal, Dizziness, Paraesthesia oral, Paraesthesia, Hyperglycaemia, |
||||
TECHNETIUM TC-99M SESTAMIBI, TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE, KIT FOR THE PREPARATION OF TECHNETIUM TC99M SESTAMIBI, |
||||
| 2503 | 25338243 |
US |
74 | 2 |
Procedural pain, Hypoaesthesia, Paraesthesia, Fatigue, |
||||
ABEMACICLIB, |
||||
| 2504 | 25338436 |
US |
49 | 2 |
Paraesthesia, |
||||
DUPILUMAB, |
||||
| 2505 | 25338479 |
US |
73 | 2 |
Decreased appetite, Musculoskeletal stiffness, Paraesthesia, Vision blurred, Diarrhoea, Erythema, Dizziness, Headache, |
||||
DUPILUMAB, |
||||
| 2506 | 25338631 |
US |
60 | 2 |
Influenza like illness, Paraesthesia, Arthralgia, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 2507 | 25328844 |
US |
53 | 2 |
Carpal tunnel syndrome, Dystonia, Suicidal ideation, Swelling, Hypoaesthesia, Pain, Burning sensation, Erythema, Urinary incontinence, Depression, Irritability, Hypoaesthesia, Peripheral swelling, Paraesthesia, Pain, Cyst, Radiculopathy, Migraine, Pain in extremity, Weight decreased, Decreased appetite, Therapeutic response shortened, Drug effect less than expected, Atrophy, Loss of personal independence in daily activities, Dyskinesia, Headache, Anxiety, Musculoskeletal stiffness, Orthostatic hypotension, Product substitution issue, |
||||
CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, GABAPENTIN, CLONAZEPAM, |
||||
| 2508 | 25329514 |
US |
65 | |
Urinary tract infection, Pruritus, Paraesthesia, Nausea, Anxiety, |
||||
GUSELKUMAB, BUDESONIDE, |
||||
| 2509 | 25329531 |
CZ |
2 | |
Paraneoplastic syndrome, Raynaud^s phenomenon, Vasculitis, Cyanosis, Pain, Pyrexia, Paraesthesia, |
||||
NIVOLUMAB, IPILIMUMAB, |
||||
| 2510 | 25329914 |
US |
83 | 1 |
Cerebrovascular accident, COVID-19, Paraesthesia, Nocturia, Asthenia, Insomnia, |
||||
RELUGOLIX, RELUGOLIX, BENAZEPRIL HYDROCHLORIDE, FISH OIL, MELATONIN, PREDNISONE, ABIRATERONE ACETATE, ABIRATERONE, |
||||
| 2511 | 25329919 |
DE |
1 | |
Paraesthesia, |
||||
EZETIMIBE, ROSUVASTATIN, INCLISIRAN, |
||||
| 2512 | 25330031 |
US |
2 | |
Fatigue, Malaise, Neuropathy peripheral, Paraesthesia, Pain, Nausea, Vomiting, Hypoaesthesia, Paraesthesia, |
||||
OLAPARIB, |
||||
| 2513 | 25330078 |
US |
2 | |
Anaphylactic reaction, Paraesthesia, |
||||
OMALIZUMAB, |
||||
| 2514 | 25330194 |
GB |
64 | 2 |
Tachycardia, Dyspnoea, Paraesthesia, |
||||
| 2515 | 25330205 |
DE |
||
Paraesthesia, |
||||
EZETIMIBE, ROSUVASTATIN, INCLISIRAN, |
||||
| 2516 | 25330517 |
78 | ||
Paraesthesia, Off label use, |
||||
RUXOLITINIB, |
||||
| 2517 | 25330692 |
US |
82 | 2 |
Drug ineffective, Arthralgia, Osteoporosis, Malaise, Fatigue, Paraesthesia, Hypertension, Mobility decreased, Somnolence, Head discomfort, Tremor, Dyspnoea, Emotional distress, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 2518 | 25330709 |
KR |
53 | 2 |
Peripheral nerve hyperexcitability, Dysarthria, Muscular weakness, Paraesthesia, Muscle twitching, Paraplegia, Muscle contractions involuntary, Sensory disturbance, Off label use, |
||||
OXALIPLATIN, OXALIPLATIN, |
||||
| 2519 | 25331092 |
US |
2 | |
Laboratory test abnormal, Nausea, Fatigue, Hair colour changes, Periorbital swelling, Product dose omission issue, Swelling face, Dry skin, Rash, Paraesthesia, Pruritus, |
||||
PEXIDARTINIB HYDROCHLORIDE, PEXIDARTINIB HYDROCHLORIDE, |
||||
| 2520 | 25331228 |
US |
2 | |
Paraesthesia, |
||||
SUZETRIGINE, |
||||
| 2521 | 25331243 |
ES |
82 | 1 |
Lung neoplasm malignant, Malignant neoplasm progression, Paraesthesia, Tremor, Muscular weakness, |
||||
CARBOPLATIN, ATEZOLIZUMAB, ETOPOSIDE, |
||||
| 2522 | 25331270 |
DE |
1 | |
Paraesthesia, |
||||
EZETIMIBE, ROSUVASTATIN, INCLISIRAN, |
||||
| 2523 | 25331329 |
GB |
2 | |
Memory impairment, Paraesthesia, Poor quality sleep, Headache, Fatigue, |
||||
| 2524 | 25331343 |
PR |
66 | 2 |
Fatigue, Muscular weakness, Rash, Erythema, Paraesthesia, White blood cell count decreased, Red blood cell count decreased, Platelet count decreased, Contusion, |
||||
LENALIDOMIDE, LENALIDOMIDE, ELOTUZUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BUPROPION HYDROCHLORIDE, SIMVASTATIN, |
||||
| 2525 | 25332382 |
US |
56 | 2 |
Guillain-Barre syndrome, Hypoaesthesia, Paraesthesia, |
||||
DUPILUMAB, |
||||
| 2526 | 25332529 |
CA |
48 | 1 |
Back pain, Chest discomfort, Dyspnoea, Erythema, Hot flush, Hyperhidrosis, Injection site pain, Paraesthesia, Rash, Urticaria, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, CABAZITAXEL, |
||||
| 2527 | 25332558 |
US |
49 | 2 |
Myelitis transverse, Spinal cord infection, Bell^s palsy, Hypoaesthesia, Paraesthesia, Pain in extremity, Hypertension, Nephropathy, Arthritis, Post procedural infection, Dry mouth, Bladder disorder, Loss of personal independence in daily activities, Dental caries, Diarrhoea, |
||||
| 2528 | 25332974 |
US |
76 | 2 |
Hypoaesthesia, Paraesthesia, Joint swelling, Hypotension, Blood pressure increased, Arthralgia, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 2529 | 25328128 |
US |
62 | 2 |
Neurodermatitis, Paraesthesia, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 2530 | 25327073 |
74 | 2 | |
Application site swelling, Application site erythema, Hypersensitivity, Paraesthesia, Rash papular, |
||||
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PREDNISONE, |
||||
| 2531 | 25327132 |
US |
54 | 1 |
Hypoaesthesia, Condition aggravated, Paraesthesia, Dry eye, Intentional product misuse, Drug ineffective, |
||||
DUPILUMAB, ALLOPURINOL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 2532 | 25327207 |
US |
73 | 2 |
Cataract, Bone pain, Sleep disorder due to a general medical condition, Chest discomfort, Paraesthesia, Eye pain, Capillary fragility, Fatigue, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 2533 | 25327366 |
CA |
||
Blood pressure increased, General physical health deterioration, Loss of personal independence in daily activities, Wheelchair user, Asthenia, Paraesthesia, Pruritus, Off label use, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE ACETATE, |
||||
| 2534 | 25327535 |
US |
47 | 2 |
Paraesthesia, Asthenia, Hypertension, Abscess, Disturbance in attention, Spinal cord disorder, Dizziness, Fatigue, Product complaint, |
||||
| 2535 | 25321861 |
US |
67 | 2 |
Burning sensation, Dyspnoea, Paraesthesia, Fatigue, Arthralgia, Swelling face, |
||||
DENOSUMAB, |
||||
| 2536 | 25321943 |
AT |
42 | 2 |
Presyncope, Anaemia, Paraesthesia, |
||||
SEMAGLUTIDE, |
||||
| 2537 | 25322004 |
GB |
35 | 2 |
Pain, Primary stabbing headache, Agitation, Executive dysfunction, Electric shock sensation, Musculoskeletal stiffness, Back pain, Tension, Sedation, Dyspnoea, Somnolence, Anxiety, Paraesthesia, |
||||
MONTELUKAST SODIUM, MONTELUKAST, |
||||
| 2538 | 25322209 |
US |
85 | 2 |
Skin burning sensation, Burning sensation, Paraesthesia, Pain in extremity, Blood pressure fluctuation, Skin discolouration, |
||||
RIPRETINIB, RIPRETINIB, RIPRETINIB, |
||||
| 2539 | 25322403 |
US |
26 | 2 |
Cataplexy, Middle insomnia, Condition aggravated, Vertigo, Paraesthesia, Dizziness, Nervousness, Fall, |
||||
SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, PITOLISANT HYDROCHLORIDE, |
||||
| 2540 | 25322436 |
EU |
63 | 2 |
Cardiomyopathy, Exercise tolerance decreased, Dilated cardiomyopathy, General physical health deterioration, Metastases to liver, Lymphadenopathy, Metastases to spleen, Metastases to central nervous system, Pulmonary mass, Paraesthesia, Muscular weakness, Central nervous system mass, Radiation necrosis, Malignant neoplasm oligoprogression, Dyspnoea, |
||||
OSIMERTINIB, |
||||
| 2541 | 25322960 |
US |
76 | 1 |
Muscular weakness, Paraesthesia, Blood pressure increased, Speech disorder, |
||||
LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, ATENOLOL, AMLODIPINE, EPINEPHRINE, ADRENALINUM, |
||||
| 2542 | 25322974 |
US |
81 | 2 |
Paraesthesia, |
||||
LENALIDOMIDE, |
||||
| 2543 | 25323248 |
US |
49 | 1 |
Vascular rupture, Scratch, Increased tendency to bruise, Paraesthesia, Neuralgia, Influenza like illness, Skin discolouration, Skin lesion, Nasopharyngitis, Cough, Pyrexia, Pain, Contusion, Dry skin, Skin fissures, Product dose omission issue, Flatulence, Nausea, Injection site haemorrhage, |
||||
TIRZEPATIDE, ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, ZANUBRUTINIB, ALLOPURINOL, AMLODIPINE BESYLATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, LOSARTAN POTASSIUM, LOSARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, OMEPRAZOLE MAGNESIUM, |
||||
| 2544 | 25323491 |
US |
||
Insomnia, Headache, Decreased appetite, Fatigue, Paraesthesia, Dysgeusia, Rhinorrhoea, Feeling cold, |
||||
ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, |
||||
| 2545 | 25323530 |
BR |
21 | 2 |
Deep vein thrombosis, Axillary vein thrombosis, Subclavian vein thrombosis, Brachiocephalic vein thrombosis, Superficial vein thrombosis, Paraesthesia, Oedema, Cyanosis, Skin fragility, Drug ineffective, |
||||
ENOXAPARIN SODIUM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, METHYLPREDNISOLONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 2546 | 25323692 |
US |
62 | 2 |
Hypoaesthesia, Paraesthesia, Sensory loss, |
||||
LENALIDOMIDE, |
||||
| 2547 | 25323734 |
US |
39 | 2 |
Feeling hot, Hypoaesthesia, Muscle spasms, Hypoaesthesia oral, Paraesthesia oral, Paraesthesia, |
||||
TRISODIUM CITRATE DIHYDRATE, NASAL, SALINE, (SALINE), |
||||
| 2548 | 25323775 |
US |
60 | 2 |
Brain fog, Paraesthesia, Central nervous system lesion, Skin lesion, Lymphocyte count decreased, |
||||
OZANIMOD HYDROCHLORIDE, OZANIMOD HYDROCHLORIDE, OZANIMOD HYDROCHLORIDE, DALFAMPRIDINE, |
||||
| 2549 | 25323850 |
US |
||
Insomnia, Headache, Decreased appetite, Fatigue, Paraesthesia, Dysgeusia, Rhinorrhoea, Feeling cold, |
||||
ACETAZOLAMIDE SODIUM, ACETAZOLAMIDE, |
||||
| 2550 | 25323920 |
GB |
78 | 2 |
Peripheral coldness, Urinary hesitation, Paraesthesia, Pain in extremity, Pyrexia, Chest pain, |
||||
ZOLEDRONIC ACID, LANSOPRAZOLE, LOSARTAN POTASSIUM, IVERMECTIN, LEVOTHYROXINE, |
||||
| 2551 | 25323998 |
US |
77 | 1 |
Skin reaction, Hypertensive urgency, Paraesthesia, Blood pressure increased, |
||||
LECANEMAB, |
||||
| 2552 | 25324118 |
US |
29 | 1 |
Paraesthesia, Erythema, Pruritus, Product use in unapproved indication, |
||||
KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, MINOXIDIL, FINASTERIDE, |
||||
| 2553 | 25324805 |
US |
||
Loss of control of legs, Influenza, General physical health deterioration, Feeling drunk, Feeling abnormal, Balance disorder, Paraesthesia, Multiple sclerosis, |
||||
UBLITUXIMAB, UBLITUXIMAB, |
||||
| 2554 | 25325247 |
BR |
39 | 2 |
Choking, Off label use, Drug hypersensitivity, Swelling face, Feeling hot, Feeling abnormal, Palpitations, Throat tightness, Chills, Dysphagia, Paraesthesia, Erythema, Pruritus, Urticaria, |
||||
DEXLANSOPRAZOLE, DEXLANSOPRAZOLE, |
||||
| 2555 | 25325290 |
US |
2 | |
Vaccination failure, Herpes zoster, Rosacea, Dermatitis contact, Paraesthesia, Seborrhoeic keratosis, Dermatitis atopic, Fatigue, Headache, Hypoaesthesia, Eyelid ptosis, Back pain, Oedema peripheral, Hyperlipidaemia, Vaccination site erythema, Vaccination site swelling, Injection site pruritus, Injection site pain, Injection site hypoaesthesia, Injection site hyperaesthesia, Neuralgia, Myalgia, Muscle strain, Ill-defined disorder, Condition aggravated, |
||||
| 2556 | 25325336 |
CO |
43 | 2 |
Delirium, Cardiac failure, Syncope, Oral pain, Mouth haemorrhage, Malignant neoplasm progression, Somnolence, General physical health deterioration, Pain of skin, Musculoskeletal pain, Bedridden, Gait disturbance, Alopecia, Gingival pain, Pain in jaw, Facial pain, Sensitive skin, Breath odour, Parosmia, Toxicity to various agents, Coagulopathy, Hair colour changes, General physical health deterioration, Migraine, Abdominal rebound tenderness, Hypoaesthesia, Paraesthesia, Migraine, Breast pain, Anxiety, Chest pain, Toothache, Abdominal distension, Flatulence, Food intolerance, Dissociation, Anxiety, Speech disorder, Slow speech, Diarrhoea, Fatigue, Pain in extremity, Asthenia, Fatigue, Fatigue, Arthralgia, Pain, Nausea, Dysgeusia, Pain in extremity, Diarrhoea, Abdominal pain upper, Abdominal pain, Gingival bleeding, Headache, Pain, Weight decreased, Bone pain, Back pain, Vomiting, Dyspnoea, Malaise, Pulmonary pain, Off label use, Off label use, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, EVEROLIMUS, EVEROLIMUS TABLETS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MORPHINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 2557 | 25325606 |
US |
||
Paraesthesia, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 2558 | 25325791 |
US |
54 | 2 |
Neuropathy peripheral, Nausea, Diarrhoea, Hot flush, Palpitations, Vomiting, Gastrooesophageal reflux disease, Thirst decreased, Abdominal pain, Localised oedema, Oedema peripheral, Dyspepsia, Dyspnoea exertional, Upper respiratory tract infection, Back pain, Abdominal discomfort, Gastrointestinal motility disorder, Nasal congestion, Chest discomfort, Cough, Hyperhidrosis, Chromaturia, Abdominal distension, Headache, Peripheral swelling, Dizziness, Paraesthesia, Blood pressure decreased, Pruritus, Nausea, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, TREPROSTINIL, RIOCIGUAT, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, FAMOTIDINE, FERROUS SULFATE, FUROSEMIDE, MACITENTAN, MAGNESIUM OXIDE, MONTELUKAST, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE, |
||||
| 2559 | 25326053 |
US |
||
Erythema, Pruritus, Pain of skin, Skin exfoliation, Paraesthesia, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 2560 | 25326174 |
US |
25 | 2 |
Paraesthesia, |
||||
OCRELIZUMAB, UBLITUXIMAB, |
||||
| 2561 | 25326507 |
US |
37 | 2 |
Nervousness, Paraesthesia, Musculoskeletal discomfort, Injection site warmth, Injection site bruising, Injection site pain, |
||||
| 2562 | 25326757 |
US |
46 | 2 |
Mental status changes, General physical condition abnormal, Limb discomfort, Paraesthesia, Arthralgia, |
||||
DUPILUMAB, |
||||
| 2563 | 25315638 |
EU |
1 | |
Paraesthesia, |
||||
ROSUVASTATIN, EZETIMIBE, INCLISIRAN, |
||||
| 2564 | 25316053 |
CA |
||
Fibromyalgia, Head discomfort, Limb discomfort, Pharyngeal paraesthesia, Psychomotor hyperactivity, Constipation, Fatigue, Fungal skin infection, Gait disturbance, Hypoaesthesia, Lower respiratory tract infection, Muscular weakness, Nasal congestion, Nasopharyngitis, Oropharyngeal discomfort, Pain in extremity, Paraesthesia, Rhinorrhoea, Off label use, Intentional product use issue, |
||||
RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 2565 | 25317379 |
EU |
48 | 1 |
Immune-mediated hyperthyroidism, Paraesthesia, |
||||
TRASTUZUMAB, TRASTUZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, PEMBROLIZUMAB, PEMBROLIZUMAB, OXALIPLATIN, OXALIPLATIN, |
||||
| 2566 | 25317474 |
US |
54 | 2 |
Atypical pneumonia, Nephrolithiasis, Ureterolithiasis, Cough, Gastrooesophageal reflux disease, Pyrexia, Fatigue, Decreased appetite, Secretion discharge, Illness, Nausea, Abdominal pain upper, Diarrhoea, Sinusitis, Respiratory disorder, Diabetic ketoacidosis, COVID-19, Perfume sensitivity, Dysphonia, Blood glucose increased, Paraesthesia, Restless legs syndrome, Pain, Gait disturbance, Glycosylated haemoglobin increased, Asthenia, Tremor, Stress, Dysphonia, Chest pain, Dyspnoea, Throat irritation, Nose deformity, Illness, Pyrexia, Wheezing, Insomnia, Sinusitis, Dehydration, Abdominal pain, Parosmia, Sinus congestion, Red blood cell count decreased, Haemoglobin, Haematocrit, Mean cell volume increased, Mean cell haemoglobin increased, Platelet aggregation abnormal, Blood immunoglobulin E decreased, FEV1/FVC ratio decreased, Asthma, Cough, Bronchial hyperreactivity, Vertigo, Anxiety, Laryngeal dyskinesia, Musculoskeletal chest pain, Renal colic, Hydronephrosis, Ureterolithiasis, |
||||
PREDNISONE, BUDESONIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, BENRALIZUMAB, |
||||
| 2567 | 25317795 |
GB |
||
Medication error, Paraesthesia, |
||||
ROSUVASTATIN, |
||||
| 2568 | 25318364 |
US |
1 | |
Paraesthesia, Skin discolouration, |
||||
RIMEGEPANT SULFATE, |
||||
| 2569 | 25318377 |
US |
73 | 1 |
Paraesthesia, |
||||
TOFACITINIB, |
||||
| 2570 | 25318811 |
FR |
66 | 2 |
Malignant neoplasm progression, Endometrial cancer, Fungal oesophagitis, Neuropathy peripheral, Paraesthesia, Urticaria, Type IV hypersensitivity reaction, Confusional state, Oral fungal infection, Asthenia, Nausea, Constipation, Abdominal pain, Anaemia, Iron deficiency, |
||||
CARBOPLATIN, PACLITAXEL, DOSTARLIMAB, |
||||
| 2571 | 25319100 |
US |
1 | |
Metastases to bone, Pain in extremity, Paraesthesia, |
||||
DAROLUTAMIDE, |
||||
| 2572 | 25319229 |
US |
||
Chest pain, Pain in extremity, Paraesthesia, |
||||
HYDROCHLOROTHIAZIDE, |
||||
| 2573 | 25319546 |
US |
37 | 2 |
Blood iron decreased, Blood potassium decreased, Gait disturbance, Insomnia, Drug ineffective, Headache, Sciatica, COVID-19, Weight increased, Drug intolerance, Tongue disorder, Urinary tract infection, Weight decreased, Chronic respiratory failure, Pain, Burning sensation, Paraesthesia, Cough, Pain in extremity, Rales, Haemoglobin decreased, Mean cell volume decreased, Blood glucose increased, Blood chloride increased, Alanine aminotransferase increased, Blood alkaline phosphatase increased, Bronchiectasis, Hepatic steatosis, Hypovitaminosis, Pulse abnormal, Body temperature fluctuation, Hypoxia, Lung infiltration, Interstitial lung disease, Infection, Dermatitis, Off label use, Off label use, Dyspnoea, Acute respiratory failure, Pneumonia, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, ALBUTEROL SULFATE, AZITHROMYCIN DIHYDRATE, CARVEDILOL, CLONAZEPAM, CLONIDINE, DILTIAZEM HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, GUAIFENESIN, KETOCONAZOLE, MEDROXYPROGESTERONE ACETATE, MONTELUKAST SODIUM, PIMECROLIMUS, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREGABALIN, SODIUM FLUORIDE, SODIUM FLUORIDE AND POTASSIUM NITRATE, PROMETHAZINE HYDROCHLORIDE, QUETIAPINE, ZOLPIDEM TARTRATE, GABAPENTIN, TOFACITINIB, LEFLUNOMIDE, AZATHIOPRINE, SEMAGLUTIDE, |
||||
| 2574 | 25320245 |
US |
43 | 1 |
Blood urea increased, Blood creatinine increased, Glomerular filtration rate decreased, Dizziness, Hypoaesthesia, Paraesthesia, |
||||
SPARSENTAN, EMPAGLIFLOZIN, MODAFINIL, ALBUTEROL SULFATE, ALBUTEROL, DEXLANSOPRAZOLE, |
||||
| 2575 | 25320779 |
US |
2 | |
Hypoaesthesia, Paraesthesia, |
||||
DUPILUMAB, |
||||
| 2576 | 25320829 |
US |
1 | |
Drug hypersensitivity, Rash, Erythema, Pruritus, Anorectal discomfort, Skin exfoliation, Paraesthesia, Skin texture abnormal, |
||||
DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, OLMESARTAN MEDOXOMIL, CARVEDILOL, |
||||
| 2577 | 25323744 |
47 | 2 | |
Hypertension, Headache, Heart rate increased, Palpitations, Paraesthesia, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 2578 | 25324092 |
27 | 2 | |
Paraesthesia, Burning sensation, Pseudostroke, Feeling abnormal, Vomiting, Panic attack, Anxiety, Agoraphobia, Suicidal ideation, General physical health deterioration, Nervous system disorder, Drug intolerance, Food intolerance, Postural orthostatic tachycardia syndrome, Migraine, Nausea, Therapy cessation, Impaired quality of life, Drug ineffective, |
||||
ESCITALOPRAM, FLUOXETINE HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 2579 | 25309874 |
US |
2 | |
Paraesthesia, Joint swelling, |
||||
LENALIDOMIDE, |
||||
| 2580 | 25310062 |
US |
2 | |
Hypoaesthesia, Paraesthesia, Product use issue, |
||||
NIRAPARIB, |
||||
| 2581 | 25310272 |
IN |
6 | 1 |
Toxic encephalopathy, Dysarthria, Fall, Gait disturbance, Sensory disturbance, Tremor, Polyneuropathy, Loss of proprioception, Myelopathy, Toxic neuropathy, Neuropathy peripheral, Paraesthesia, Body temperature decreased, Parkinson^s disease, Multiple sclerosis, Vertebrobasilar stroke, Transient ischaemic attack, Toxicity to various agents, Skin hyperpigmentation, Overdose, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 2582 | 25310503 |
US |
30 | 1 |
Paraesthesia, Flushing, Nausea, Vomiting, Diarrhoea, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, |
||||
| 2583 | 25310600 |
US |
||
Feeling abnormal, Paraesthesia, Nausea, Fatigue, Hot flush, |
||||
RELUGOLIX, RELUGOLIX, ATENOLOL, EVOLOCUMAB, ROSUVASTATIN CALCIUM, |
||||
| 2584 | 25310635 |
US |
2 | |
Immediate post-injection reaction, Paraesthesia, Pharyngeal paraesthesia, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 2585 | 25310980 |
55 | 1 | |
Neurotoxicity, Toxicity to various agents, Dysarthria, Gait disturbance, Hypoaesthesia, Paraesthesia, Nausea, Vomiting, Ataxia, Intention tremor, Hyperreflexia, Off label use, |
||||
METRONIDAZOLE, METRONIDAZOLE TOPICAL, CEFTRIAXONE, CEFTRIAXONE SODIUM, METRONIDAZOLE, METRONIDAZOLE TOPICAL, |
||||
| 2586 | 25311306 |
US |
2 | |
Paraesthesia, Dizziness, |
||||
ZURANOLONE, |
||||
| 2587 | 25311347 |
US |
48 | 2 |
Skin discolouration, Fatigue, Paraesthesia, Headache, |
||||
BREMELANOTIDE, BREMELANOTIDE, |
||||
| 2588 | 25311497 |
US |
58 | 2 |
Pruritus, Paraesthesia, Insomnia, Somnolence, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 2589 | 25311680 |
US |
50 | 2 |
Pain, Loss of personal independence in daily activities, Pain in extremity, Paraesthesia, |
||||
CAPSAICIN, |
||||
| 2590 | 25311681 |
US |
41 | 2 |
Paraesthesia, Hypoaesthesia, Pain in extremity, Burning sensation, Product use issue, Pain, |
||||
CAPSAICIN, CAPSAICIN, |
||||
| 2591 | 25312346 |
US |
31 | 2 |
Rheumatoid arthritis, Burning sensation, Dry eye, Paraesthesia, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 2592 | 25312366 |
US |
||
Paraesthesia, Feeling abnormal, Insomnia, |
||||
| 2593 | 25312390 |
US |
41 | 2 |
Neuropathy peripheral, Gait inability, Neuralgia, Paraesthesia, Decreased activity, Decreased appetite, Palmar-plantar erythrodysaesthesia syndrome, Blister, Flatulence, Adverse drug reaction, Product use issue, |
||||
REGORAFENIB, |
||||
| 2594 | 25312427 |
US |
42 | 2 |
Oral discomfort, Burning sensation, Paraesthesia oral, Paraesthesia, Skin burning sensation, Hypersensitivity, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 2595 | 25312598 |
EU |
48 | 1 |
Immune-mediated hyperthyroidism, Paraesthesia, |
||||
TRASTUZUMAB, TRASTUZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, LEUCOVORIN CALCIUM, LEUCOVORIN CALCIUM, OXALIPLATIN, OXALIPLATIN, PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 2596 | 25312852 |
GB |
78 | 2 |
Pain in extremity, Peripheral coldness, Pyrexia, Paraesthesia, Chest pain, Urinary hesitation, |
||||
ZOLEDRONIC ACID, IVERMECTIN, LOSARTAN POTASSIUM, LANSOPRAZOLE, LEVOTHYROXINE, |
||||
| 2597 | 25312943 |
US |
1 | |
Paraesthesia, Hypoaesthesia, Blood pressure diastolic decreased, Dizziness, |
||||
SPARSENTAN, |
||||
| 2598 | 25312984 |
NZ |
41 | 2 |
Sneezing, Paraesthesia, Urticaria, Rash, |
||||
IOHEXOL, |
||||
| 2599 | 25313520 |
43 | 2 | |
Muscular weakness, Dysstasia, Gait inability, Hypoaesthesia, Paraesthesia, Hypoaesthesia, Paraesthesia, Chest pain, |
||||
ROSUVASTATIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ROSUVASTATIN, LOSARTAN, INSULIN GLARGINE, INSULIN LISPRO, NORETHINDRONE, GABAPENTIN, LORAZEPAM, |
||||
| 2600 | 25313983 |
BE |
55 | 2 |
Calculus urinary, Depression, Paraesthesia, Aphasia, |
||||
ESCITALOPRAM OXALATE, ESCITALOPRAM, TRAZODONE HYDROCHLORIDE, TOPIRAMATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30